Serosurveillance and the COVID-19 Epidemic in the US: Undetected, Uncertain, and Out of Control

Tyler S Brown^{1

2}, Rochelle P Walensky^{1

2

3}

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston.
² Harvard Medical School, Boston, Massachusetts.
³ Medical Practice Evaluation Center, Massachusetts General Hospital, Boston.

Editorial

Tyler S Brown et al. JAMA. 2020.

. 2020 Aug 25;324(8):749-751.

doi: 10.1001/jama.2020.14017.

Tyler S Brown^{1

2}, Rochelle P Walensky^{1

2

3}

¹ Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston.
² Harvard Medical School, Boston, Massachusetts.
³ Medical Practice Evaluation Center, Massachusetts General Hospital, Boston.

No abstract available

Comment on

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020.
Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, Fry AM, Cannon DL, Chiang CF, Gibbons A, Krapiunaya I, Morales-Betoulle M, Roguski K, Rasheed MAU, Freeman B, Lester S, Mills L, Carroll DS, Owen SM, Johnson JA, Semenova V, Blackmore C, Blog D, Chai SJ, Dunn A, Hand J, Jain S, Lindquist S, Lynfield R, Pritchard S, Sokol T, Sosa L, Turabelidze G, Watkins SM, Wiesman J, Williams RW, Yendell S, Schiffer J, Thornburg NJ. Havers FP, et al. JAMA Intern Med. 2020 Jul 21;180(12):1576-86. doi: 10.1001/jamainternmed.2020.4130. Online ahead of print. JAMA Intern Med. 2020. PMID: 32692365 Free PMC article.